Consequently, identification of new prognostic markers is of utmost importance to achieve tailored therapy.42 The Cox analysis in our study revealed that Cdc20 is an independent prognostic factor in DLBCL and Cdc20 protein expression seems to be linked to a poor prognosis in DLBCL patients. Here, CDC20 is linked to diffuse large B-cell lymphoma.